Ars
- REVIEWS
Calling all Ars readers! Your feedback is needed.
Many of you know that most of our staff is spread out all over these United States, but what you…
Read More » - REVIEWS
Ars Live: Our first encounter with manipulative AI
While Bing Chat’s unhinged nature was caused in part by how Microsoft defined the “personality” of Sydney in the system…
Read More » - REVIEWS
The Ars redesign is out. Experience its ad-free glory for just $25/year.
Whew—the big event is finally behind us. I’m talking, of course, about the Ars Technica version 9 redesign, which we…
Read More » - REVIEWS
The Ars redesign 9.0.2 brings the text options you’ve requested
Readers of those other sites may not care much about font size and column widths. “40-character line lengths? In 18-point…
Read More » - REVIEWS
Ars Live: What else can GLP-1 drugs do? Join us Tuesday for a discussion.
News and talk of GLP-1 drugs are everywhere these days—from their smash success in treating Type 2 diabetes and obesity…
Read More » - REVIEWS
When ribosomes go rogue – Ars Technica
In the 1940s, scientists at the recently established National Cancer Institute were trying to breed mice that could inform our…
Read More » - REVIEWS
Ars 9.0.1 redesign is now live, with density tweaks and visited link colors
We love all the feedback that Ars readers have submitted since we rolled out the Ars Technica 9.0 design last…
Read More » - REVIEWS
Ars’ next conference is coming October 29 in Washington, D.C.
After a great event last month in San Jose, Ars is switching coasts for October and descending in force on…
Read More » - REVIEWS
Ars Prime Day 2024 Techstravaganza: The best deals on the best things
Get ready to transform and roll out, Arsians: It’s Prime Day! Named in honor of famous Autobot leader Optimus Prime,…
Read More » - REVIEWS
Medicine Nobel for microRNAs – Ars Technica
Based on the stereotypical hairpin structure, researchers have scanned genomes and found over 38,000 likely precursors; nearly 50,000 mature microRNAs…
Read More »
